drugset / Trial / NCT02111083

A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants

NCT02111083

Phase 1 Completed 38 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindBasic science

Summary

The study involves 4 injections of insulin lispro and its purpose is to: * Determine if 2 formulations of insulin lispro are treated by the body in a similar way. * Compare how the 2 formulations of insulin lispro affect blood sugar level. * Determine the safety of each insulin lispro formulations and any side effects that might be associated with them when given to healthy participants. The study is expected to last up to approximately 9 weeks for each participant.

Timeline

Start
2014-05
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic 20 iu Subcutaneous

Indications

No indication recorded.